The results showed that the OS time of glioma patients with higher TMEM158 expression was shorter than that of glioma patients with lower TMEM158 expression in the TCGA RNA-seq database (p < 0.0001) (Fig. 1H). The gene discussed is TMEM158; the disease is central nervous system cancer.